Saksenaea dorisiae sp. nov., a New Opportunistic Pathogenic Fungus from Europe

Figure 5

In vitro antifungal susceptibility of Saksenaea dorisiae BiMM-F232 towards selected antifungals after 3 days incubation at 37°C. MIC Test strips: (a) posaconazole (POS), (b) itraconazole (ITC), (c) ketoconazole (KE), (d) caspofungin (CAS), (e) flucytosine (FC),(f) fluconazole (FLU), (g) voriconazole (VO), (h) amphotericin B (AMB), and (i) antifungal discs(left top to left bottom: ketoconazole KCA 15 μg and itraconazole ITC 8 and 15 μg; right top to right bottom: clotrimazole CLO 50 μm and fluconazole FLU 25 and 100 μm); all plates were overgrown by the fungus after prolonged incubation (5 days) at 37°C.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)